HoLEP surgery
ProcedureAll parameters are part of routine clinical practice; no additional examinations are required
NCT Number: NCT07655830
This study aims to evaluate the changes between preoperative and postoperative serum chloride levels in patients undergoing HoLEP surgery and to investigate the metabolic and clinical effects of this change. The study is observational, and no additional interventions will be performed.
Trial opening soon.
Get Notified18 year and older
Male
Observational
Although isotonic irrigation fluids used in HoLEP surgery reduce the risk of hyponatremia associated with TUR syndrome, high-volume fluid absorption may lead to hyperchloremia and subsequent metabolic acidosis. This prospective, observational, single-center study, conducted at Ankara Bilkent City Hospital, aims to identify early markers of this condition to optimize perioperative management.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All parameters are part of routine clinical practice; no additional examinations are required
Time frame: Perioperative
Time frame: Perioperative
Time frame: Perioperative
Ankara City Hospital Bilkent
Other
Evaluation of the Metabolic and Clinical Effects of Intraoperative Hyperchloremia in Holmium Laser Enucleation of Prostate (HoLEP) Surgery.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07310056
Bronchial Neoplasms, Carcinoma, Bronchogenic
View Trial DetailsNCT06374823
Brain Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07339202
Chronic Disease, Disease Attributes
Stanford, California, United States
View Trial DetailsNCT06766539
Attention Distribution, Eye-tracking Technology
Hangzhou, Zhejiang, China
View Trial Details